Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Confident About Evusheld's Future Growth

As Next-Generation Version Moves Towards Clinic

AstraZeneca — • Source: Shutterstock: Elzbieta Krzysztof

Related Content

Evusheld: UK Urged To Use RWD To Give Clinically Vulnerable Early Access To COVID-19 Treatment

Sep 30 2022

At Last, AZ’s Imfinzi/Tremelimumab Cancer Combo Shows Survival Benefit

May 07 2021

AstraZeneca CTLA-4 Inhibitor Imjudo (Finally) Wins FDA Approval

Oct 24 2022

AZ’s Evusheld Receives World-First Approval As COVID-19 Treatment, In Japan

Aug 31 2022

Related Companies

AstraZeneca PLC

Additional Topics

Coronavirus COVID-19 Business Strategies Sales & Earnings Commercial Real-World Evidence BioPharmaceutical

More from COVID-19

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window